New tech has potential to tackles manufacturing bottlenecks in blood cancer treatment
Manufacturer's Monthly
JULY 22, 2024
UniSA’s Future Industries Institute PhD graduate Dr Mona Elsemary said ensuring the purity of T-cells extracted from patients is a challenge and a key bottleneck in the routine clinical use of this ground breaking immunotherapy.
Let's personalize your content